FrancophonIA/ELRC3.0 huggingface dataset:
English: Hepatic impairment: Careful dose titration is recommended in patients with mild hepatic impairment (see sections 4.4 and 5.2).
Danish: Nedsat leverfunktion: Forsigtig dosistitrering anbefales hos patienter med let nedsat leverfunktion (se pkt.
English: Pale green oval-shaped tablet engraved with 750 on one side.
Danish: Depottablet Lysegrøn, oval tablet præget med 750 på den ene side.
English: Ranexa may cause dizziness, blurred vision, diplopia, confusional state, coordination abnormal, hallucination (see section 4.8), which may affect the ability to drive and use machines.
Danish: Ranexa kan medføre svimmelhed, sløret syn, diplopi, konfusion, koordinationsforstyrrelser og hallucinationer (se pkt.
English: CHF: CHF NYHA Class III and IV were estimated to have about 1.3-fold higher plasma concentrations.
Danish: Kronisk hjerteinsufficiens: Patienter med kronisk hjerteinsufficiens (NYHA-klasse III og IV) vurderedes at have en 1,3 gange højere plasmakoncentration.
English: You should not take Ranexa if you are breast-feeding.
Danish: Amning Du bør ikke tage Ranexa, hvis du ammer.
English: • Concomitant administration of P-gp inhibitors (see sections 4.2 and 4.5).
Danish: • Samtidig administration af P-glykoproteinhæmmere (se pkt.
English: S.A.
Danish: S.R.L.
English: EU/1/08/462/001 60 tablets in blister pack EU/1/08/462/002 60 tablets in bottle EU/1/08/462/007 30 tablets in blister pack EU/1/08/462/008 100 tablets in blister pack
Danish: EU/1/08/462/001 60 tabletter i blisterpakning EU/1/08/462/002 60 tabletter i flaske EU/1/08/462/007 30 tabletter i blisterpakning EU/1/08/462/008 100 tabletter i blisterpakning
English: EU/1/08/462/003 60 tablets in blister pack EU/1/08/462/004 60 tablets in bottle EU/1/08/462/009 30 tablets in blister pack EU/1/08/462/010 100 tablets in blister pack
Danish: EU/1/08/462/003 60 tabletter i blisterpakning EU/1/08/462/004 60 tabletter i flaske EU/1/08/462/009 30 tabletter i blisterpakning EU/1/08/462/010 100 tabletter i blisterpakning
English: Electrocardiographic effects: Dose and plasma concentration-related increases in the QTc interval (about 6 msec at 1000 mg twice daily), reductions in T wave amplitude, and in some cases notched
Danish: Elektrokardiografisk virkning: Der er observeret dosis- og plasmakoncentrationsrelaterede stigninger i QTc-intervallet (ca. 6 msek.
English: EU/1/08/462/005 60 tablets in blister pack EU/1/08/462/006 60 tablets in bottle EU/1/08/462/011 30 tablets in blister pack EU/1/08/462/012 100 tablets in blister pack
Danish: EU/1/08/462/005 60 tabletter i blisterpakning EU/1/08/462/006 60 tabletter i flaske EU/1/08/462/011 30 tabletter i blisterpakning EU/1/08/462/012 100 tabletter i blisterpakning
English: Polyvinyl alcohol-part hydrolyzed Iron oxide yellow (E172) Iron oxide red (E172) Talc
Danish: Jernoxid, rød (E172)
English: An increased incidence of adverse events was seen among ranolazine treated patients in the RIVERPCI trial (see section 5.1) where patients with incomplete revascularization post-PCI were given ranolazine up to 1000 mg twice daily or placebo for approximately 70 weeks.
Danish: 5.1), hvor patienter med ufuldstændig revaskularisering efter PCI fik op til 1000 mg ranolazin to gange dagligt eller placebo i ca. 70 uger.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each prolonged-release tablet contains 375 mg ranolazine.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver depottablet indeholder 375 mg ranolazin.
English: Ranexa 1000 mg twice daily increased plasma concentrations of simvastatin lactone, simvastatin acid by about 2 fold.
Danish: Ranexa 1.000 mg to gange dagligt fik plasmakoncentrationen af simvastatinlacton og simvastatinsyre til at stige med cirka en faktor 2.
English: NAME OF THE MEDICINAL PRODUCT Ranexa 500 mg prolonged-release tablets Ranolazine
Danish: LÆGEMIDLETS NAVN Ranexa 500 mg depottabletter Ranolazin
English: Posology Ranexa is available as 375 mg, 500 mg, and 750 mg prolonged-release tablets.
Danish: Dosering Ranexa fås som depottabletter med 375 mg, 500 mg og 750 mg.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each prolonged-release tablet contains 500 mg ranolazine.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver depottablet indeholder 500 mg ranolazin.
English: CYP2D6 inhibitors: Ranolazine is partially metabolised by CYP2D6; therefore, inhibitors of this enzyme may increase plasma concentrations of ranolazine.
Danish: CYP2D6-hæmmere: Ranolazin metaboliseres delvist af CYP2D6.
English: Moderate or severe hepatic impairment (see sections 4.2 and 5.2).
Danish: Moderat eller svært nedsat leverfunktion (se pkt.
English: NAME OF THE MEDICINAL PRODUCT Ranexa 375 mg prolonged-release tablets Ranolazine
Danish: LÆGEMIDLETS NAVN Ranexa 375 mg depottabletter Ranolazin
English: EXP
Danish: Talcum
English: Your doctor may decide to give you a lower dose or take other precautions if any of these apply to you.
Danish: Hvis noget af det ovenstående gælder for dig, er det muligt, at din læge nedsætter din dosis eller ændrer din behandling på anden vis.
English: Warning and precautions
Danish: Kvalme og opkastning
English: Throat tightness
Danish: Nyrer og urinveje
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each prolonged-release tablet contains 750 mg ranolazine.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver depottablet indeholder 750 mg ranolazin.
English: NAME OF THE MEDICINAL PRODUCT Ranexa 750 mg prolonged-release tablets Ranolazine
Danish: LÆGEMIDLETS NAVN Ranexa 750 mg depottabletter Ranolazin
English: Electrocardiographic effects: Dose and plasma concentration-related increases in the QTc interval (about 6 msec at 1000 mg twice daily), reductions in T wave amplitude, and in some cases notched T waves, have been observed in patients treated with Ranexa.
Danish: ved 1.000 mg to gange dagligt), reduktion af T-takkens amplitude og i nogle tilfælde difasiske T-takker hos patienter i behandling med Ranexa.
English: Dose titration in patients with low weight should be exercised with caution (see sections 4.4, 4.8, and 5.2).
Danish: Dosistitrering hos patienter med lav kropsvægt skal gennemføres med forsigtighed (se pkt.
English: Ranexa may cause dizziness, blurred vision, diplopia, confusional state, coordination abnormal, and hallucination (see section 4.8), which may affect the ability to drive and use machines.
Danish: forvirring (ikke almindeligt), hallucinationer (ikke almindeligt), dobbeltsyn (ikke almindeligt) eller koordinationsforstyrrelser (sjældent), som kan påvirke din evne til at køre eller betjene maskiner.
English: Muscle cramp
Danish: Muskelkramper
English: Severe renal impairment (creatinine clearance < 30 ml/min) (see sections 4.2 and 5.2).
Danish: Svært nedsat nyrefunktion defineret som kreatininclearance på < 30 ml/min (se pkt.
English: Renal and urinary disorders Uncommon: dysuria, haematuria, chromaturia.
Danish: Ikke almindelig: dysuri, hæmaturi, kromaturi.
English: Skin and subcutaneous tissue disorders Uncommon: pruritus, hyperhydrosis.
Danish: Ikke almindelig: pruritus, hyperhidrosis.
English: The risk of all cause mortality, CV death or major adverse cardiovascular events (MACE) and heart failure hospitalisation was similar between treatment groups in the overall population; however, MACE were reported more frequently in patients ≥ 75 years treated with ranolazine compared with placebo (17.0% vs 11.3%, respectively); in addition there was a numerical increase in all cause mortality in patients ≥ 75 years (9.2% vs. 5.1%, p = 0.074).
Danish: Der blev dog indberettet flere tilfælde af alvorlige kardiovaskulære hændelser (MACE) for patienter ≥ 75 år, der blev behandlet med ranolazin sammenlignet med placebo (hhv. 17,0 % vs. 11,3 %).
English: Dose limitation of other statins, metabolised by CYP3A4 (e.g. lovastatin), may be considered when taking Ranexa.
Danish: Hos patienter, der får Ranexa, bør det overvejes at begrænse dosis af andre statiner, der metaboliseres af CYP3A4 (f.eks. lovastatin).
English: Check with your doctor or pharmacist if you are not sure.
Danish: - Spørg lægen eller på apoteket, hvis der er mere, du vil vide.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 375 mg of ranolazine.
Danish: Hver tablet indeholder 375 mg ranolazin.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 750 mg of ranolazine.
Danish: Hver tablet indeholder 750 mg ranolazin.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 500 mg of ranolazine.
Danish: Hver tablet indeholder 500 mg ranolazin.
English: Feeling sick, vomiting
Danish: Uklart syn, synsforstyrrelser
English: België/Belgique/Belgien Menarini Benelux NV/SA Tél/Tel: + 32 (0)2 721 4545
Danish: Hvis du vil have yderligere oplysninger om Ranexa, skal du henvende dig til den lokale repræsentant: België/Belgique/Belgien Menarini Benelux NV/SA Tél/Tel: + 32 (0)2 721 4545
English: Do not use the following medicines if you take Ranexa: - certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections
Danish: Brug af anden medicin sammen med Ranexa Brug ikke følgende medicin, hvis du tager Ranexa: - visse former for medicin, der bruges til behandling af bakterielle infektioner (clarithromycin, telithromycin), svampeinfektioner (itraconazol, ketoconazol, voriconazol, posaconazol), hivinfektion (proteasehæmmere), depression (nefazodon) eller forstyrrelser i hjerterytmen (f.eks. quinidin, dofetilid eller sotalol).
English: Date of first authorisation: 04 November 2009 Date of latest renewal: 04 July 2014
Danish: Dato for første markedsføringstilladelse: 4. november 2009 Dato for seneste fornyelse: 4. juli 2014
English: Not known (frequency cannot be estimated from the available data):
Danish: Ikke kendt (hyppigheden kan ikke vurderes ud fra tilgængelig data)
English: Other side effects may include:
Danish: Andre bivirkninger kan være:
English: Some side effects can be serious and need immediate medical attention.
Danish: Nogle bivirkninger kan være alvorlige og kræver omgående lægebehandling.
English: Caution should be used with:
Danish: Forsigtighed skal udvises ved brug af:
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Danish: Kravene for fremsendelsen af periodiske, opdaterede sikkerhedsindberetninger for dette lægemiddel fremgår af listen over EU-referencedatoer (EURD list), som fastsat i artikel 107c, stk. 7, i direktiv 2001/83/EF, og alle efterfølgende opdateringer offentliggjort på den europæiske webportal for lægemidler.
English: Follow your doctor's instructions for the starting dose carefully.
Danish: Følg nøje lægens anvisning vedrørende startdosis nøje.
English: If you experience these symptoms, do not drive or use tools or machines.
Danish: Hvis du oplever disse symptomer, må du ikke køre bil eller betjene maskiner.
English: Volume of distribution is approximately 21 l/kg.
Danish: Fordelingsvolumen er omkring 21 l/kg.
English: As for any combination containing three active substances, side effects associated with each individual component cannot be excluded.
Danish: Som for enhver kombination, der indeholder tre aktive stoffer, kan bivirkninger forbundet med hver enkelt komponent ikke udelukkes.
English: Consult a doctor immediately if you experience any of the following serious side effects after taking this medicine:
Danish: Kontakt omgående din læge, hvis du får hvilken som helst af følgende alvorlige bivirkninger efter du har taget dette lægemiddel:
English: if you have had skin cancer or if you develop an unexpected skin lesion during the treatment.
Danish: - hvis du har haft hudkræft, eller hvis du udvikler en uventet hudlæsion under behandlingen.
English: Steady-state plasma levels are reached after continuous administration for 7-8 days.
Danish: Steadystate-plasmaniveauerne opnås efter vedvarende administration i 7-8 dage.
English: Valsartan is not transformed to a high extent as only about 20% of dose is recovered as metabolites.
Danish: Valsartan omdannes ikke i stor grad, da kun omkring 20 % af dosis genfindes som metabolitter.
English: • verapamil, diltiazem (heart medicines);
Danish: • verapamil, diltiazem (hjertemedicin);
English: Paediatric patients (age below 18 years) No pharmacokinetic data are available in the paediatric population.
Danish: Pædiatriske patienter (under 18 år) Der er ingen farmakokinetiske data tilgængelige for den pædiatriske population.
English: Biotransformation Amlodipine is extensively (approximately 90%) metabolised in the liver to inactive metabolites.
Danish: Biotransformation Amlodipin bliver i udstrakt grad (ca. 90 %) metaboliseret i leveren til inaktive metabolitter.
English: • vitamin D and calcium salts.
Danish: • D-vitamin og calciumsalte.
English: Shock (including cardiogenic shock).
Danish: - Shock, herunder kardiogent shock.
English: Caution is indicated in long-term administration of these medicinal products.
Danish: Forsigtighed skal iagttages ved langtidsbehandling med disse lægemidler.
English: • Obligation to conduct post-authorisation measures The MAH shall complete, within the stated timeframe, the below measures:
Danish: • Forpligtelse til at gennemføre foranstaltninger efter udstedelse af markedsføringstilladelse Indehaveren af markedsføringstilladelsen skal inden for den fastsatte tidsramme gennemføre følgende foranstaltninger:
English: Anticholinergic agents and other medicinal products affecting gastric motility
Danish: Antikolinerge midler og andre lægemidler, som påvirker den gastrointestinale motilitet
English: Therefore, Dafiro HCT is not recommended in this population.
Danish: Dafiro HCT anbefales derfor ikke til denne population.
English: This medicine may make you feel dizzy, drowsy, nauseous or have a headache.
Danish: Denne medicin kan få dig til at føle svimmelhed, døsighed, kvalme eller få hovedpine.
English: The apparent volume of distribution is 4-8 l/kg.
Danish: Distributionsvolumenet er 4-8 l/kg.
English: Valsartan is primarily eliminated in faeces (about 83% of dose) and urine (about 13% of dose), mainly as unchanged drug.
Danish: Valsartan udskilles primært i fæces (omkring 83 % af dosis) og i urin (omkring 13 % af dosis) hovedsageligt som uomdannet stof.
English: Therefore careful monitoring of serum lithium concentrations is recommended during concomitant use.
Danish: Derfor anbefales tæt monitorering af lithiumkoncentrationen i serum ved samtidig brug.
English: Severe hypotension.
Danish: - Svær hypotension.
English: Children and adolescents The use of Dafiro HCT in children and adolescents under 18 years of age is not recommended.
Danish: Børn og unge Brug af Dafiro HCT til børn og unge under 18 år frarådes.
English: You should never take Dafiro HCT again.
Danish: Du bør aldrig tage Dafiro HCT igen.
English: • increased need to urinate at night
Danish: • øget behov for vandladning om natten
English: However, it is important to take into account that Dafiro HCT may increase the hypotensive effect of other antihypertensive agents.
Danish: Det er imidlertid vigtigt at tage i betragtning, at Dafiro HCT kan øge den hypotensive virkning af andre antihypertensive stoffer.
English: if you have experienced a heart attack.
Danish: - hvis du har haft et hjerteanfald.
English: Dafiro HCT is not recommended in early pregnancy and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Danish: Dafiro HCT frarådes i den tidlige periode af graviditeten og må ikke tages, når du er mere end 3 måneder henne i graviditeten, fordi det kan forårsage alvorlig skade på dit barn, hvis det tages efter tredje graviditetsmåned.
English: Since the three components are equally well tolerated in younger and elderly patients, normal dose regimens are recommended (see section 4.2).
Danish: Eftersom de tre aktive stoffer er lige veltolererede hos yngre og ældre patienter anbefales de normale doseringer (se pkt.
English: Increase of dose of probenecid or sulfinpyrazone may be necessary.
Danish: En øget dosis af probenecid eller sulfinpyrazon kan være nødvendig.
English: Dafiro HCT was studied in a double-blind, active controlled study in hypertensive patients.
Danish: Dafiro HCT er blevet undersøgt i et dobbeltblindet, aktivt-kontrolleret studie hos hypertensive patienter.
English: Do not take Dafiro HCT with grapefruit or grapefruit juice.
Danish: Tag ikke Dafiro HCT sammen med grapefrugt eller grapefrugtjuice.
English: The increase in mean AUC is linear and dose proportional in the therapeutic range.
Danish: Stigningen i middelAUC er lineær og proportional med dosis i det terapeutiske område.
English: • nitroglycerin and other nitrates, or other substances called “vasodilators”;
Danish: • glyceryltrinitrat (nitroglycerin) og andre nitrater eller andre stoffer, som kaldes ”vasodilatorer”
English: The dose of Dafiro HCT should be based on the doses of the individual components of the combination at the time of switching.
Danish: Doseringen af Dafiro HCT skal baseres på doserne af de individuelle komponenter i kombinationen ved tidspunktet for omskiftningen.
English: Before switching to Dafiro HCT patients should be controlled on stable doses of the monocomponents taken at the same time.
Danish: Inden skift til Dafiro HCT skal patienter være kontrolleret på stabile doser af monokomponenterne taget på samme tid.
English: Cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus
Danish: Kutane lupus erythematosuslignende reaktioner, reaktivering af kutan lupus erythematosus
English: There is no relevant use of Dafiro HCT in the paediatric population (patients below age 18 years) for the indication of essential hypertension.
Danish: Det er ikke relevant at anvende Dafiro HCT hos den pædiatriske population (patienter under 18 år) til indikationen essentiel hypertension.
English: Patients with mild to moderate renal impairment may therefore receive the usual initial dose (see sections 4.2 and 4.4).
Danish: Patienter med let til moderat nedsat nyrefunktion kan derfor få normal startdosis (se pkt 4.2 og 4.4).
English: The steady-state volume of distribution of valsartan after intravenous administration is about 17 litres, indicating that valsartan does not distribute into tissues extensively.
Danish: Steady-state fordelingsvolumen af valsartan efter intravenøs administration er omkring 17 liter, hvilket tyder på, at valsartan ikke fordeles i udtalt grad i væv.
English: Hydrochlorothiazide is eliminated from plasma with a half-life averaging 6 to 15 hours in the terminal elimination phase.
Danish: Hydrochlorthiazid elimineres fra plasma med en gennemsnitlig halveringstid på 6 til 15 timer i den terminale eliminationsfase.
English: See also information under the heading “Do not take Dafiro HCT”.
Danish: Se også information under ovrskriften ”Tag ikke Dafiro HCT”.
English: Some of these patients previously experienced angioedema with other medicinal products including ACE inhibitors.
Danish: Nogle af disse patienter havde tidligere udviklet angioødem ved behandling med andre lægemidler, herunder ACE-hæmmere.
English: Hypromellose, substitution type 2910 (3 mPa.s) Macrogol 4000
Danish: Hypromellose, substitutionstype 2910 (3 mPa.s) Macrogol 4000
English: Medicinal products that could induce torsades de pointes
Danish: Lægemidler som kan forårsage torsades de pointes
English: Patients with hepatic impairment have decreased clearance of amlodipine with resulting increase of approximately 40-60% in AUC.
Danish: Patienter med nedsat leverfunktion har nedsat udskillelse af amlodipin, hvilket medfører et øget AUC på ca. 40-60 %.
English: The usual dose of Dafiro HCT is one tablet per day.
Danish: Den sædvanlige dosis af Dafiro HCT er én tablet daglig.
English: • increased muscle tension
Danish: • øget muskelspænding
English: Valsartan shows multiexponential decay kinetics (t½α <1 h and t½ß about 9 h).
Danish: Valsartan udviser multieksponentiel halveringskinetik (t½α <1 time og t½ß omkring 9 timer).
English: The full blood pressure lowering effect was achieved 2 weeks after being on their maximal dose of Dafiro HCT.
Danish: Den fulde blodtrykssænkende effekt blev opnået 2 uger efter, at patienterne fik den maksimale dosis af Dafiro HCT.
English: • blistering skin (sign of a condition called dermatitis bullous)
Danish: • blærer på huden (tegn på en lidelse kaldet bulløs dermatit)
English: Always take this medicine exactly as your doctor has told you.
Danish: Tag altid lægemidlet nøjagtig efter lægens anvisning.
English: These could be symptoms of an increase of pressure in your eye and can happen within hours to a week of taking Dafiro HCT.
Danish: Dette kan være symptomer på øget tryk i øjet og kan opstå inden for timer eller en uge efter indtagelse af Dafiro HCT.
English: Upon co-administration of known inducers of the CYP3A4, the plasma concentration of amlodipine may vary.
Danish: Ved samtidig administration af kendte CYP3A4induktorer kan plasmakoncentrationen af amlodipin variere.
English: Another study showed a possible association between lip cancer (SCC) and exposure to hydrochlorothiazide: 633 cases of lip cancer were matched with 63,067 population controls, using a risk-set sampling strategy.
Danish: Et andet studie viste en mulig forbindelse mellem læbekræft (pladecellekarcinom) og eksponering for hydrochlorthiazid: 633 tilfælde af læbekræft blev matchet med 63.067 forsøgspersoner i kontrolgrupper under anvendelse af en risk set sampling-strategi.
English: Valsartan is mostly eliminated unchanged via the bile.
Danish: Valsartan udskilles hovedsageligt uforandret via galden.
English: Do not use any Dafiro HCT pack that is damaged or shows signs of tampering.
Danish: Brug ikke pakninger med Dafiro HCT, som er beskadiget eller viser tegn på at have været forsøgt åbnet.
English: Angioedema, including swelling of the larynx and glottis, causing airway obstruction and/or swelling of the face, lips, pharynx, and/or tongue, has been reported in patients treated with valsartan.
Danish: Angioødem, herunder opsvulmning af larynx og glottis, som forårsager luftvejsobstruktion, og/eller hævelse af ansigt, læber, svælg og/eller tunge er blevet rapporteret hos patienter i behandling med valsartan.
English: Protect your skin from sun exposure and UV rays while taking Dafiro HCT.
Danish: Beskyt huden mod sollys og UVstråler, mens du tager Dafiro HCT.
English: As with all other vasodilators, special caution is indicated in patients with mitral stenosis or significant aortic stenosis that is not high grade.
Danish: Som med alle andre vasodilatorer skal der udvises særlig forsigtighed over for patienter, der lider af mitralklapstenose eller signifikant aortastenose, som ikke er af høj grad.
English: The recommended dose of Dafiro HCT is one tablet per day, to be taken preferably in the morning.
Danish: Den anbefalede dosis af Dafiro HCT er én tablet dagligt, som helst skal tages om morgenen.
English: Uncommon (may affect up to 1 in 100 people): • severely decreased urine output (decreased kidney function)
Danish: Ikke almindelig (kan forekomme hos op til 1 ud af 100 personer) • meget nedsat vandladning (nedsat nyrefunktion)
English: +Cl symporter perhaps by competing for the Cl site,
Danish: --symporteren, muligvis ved at konkurrere om C1
English: Other: dual blockade of the renin-angiotensin-aldosterone system (RAAS)
Danish: Andet: dobbeltblokade af renin-angiotensin-aldosteronsystemet (RAAS)
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu
Danish: Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs hjemmeside http:/www.ema.europa.eu
English: Amlodipine has been studied in patients with chronic stable angina, vasospastic angina and angiographically documented coronary artery disease.
Danish: Amlodipin er blevet undersøgt til patienter med kronisk stabil angina, vasospastisk angina og angiografisk dokumenteret koronarterielidelse.